Stonehage Fleming Financial Services Holdings LTD Theravance Biopharma, Inc. Transaction History

Stonehage Fleming Financial Services Holdings LTD

$3.78 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2015 Oct 11, 2019	SELL	N/A	-10,900 Closed	0 $0
Q1 2015 Oct 11, 2019	SELL	N/A	-5,300 Reduced 32.72%	10,900 $189,000
Q4 2014 Oct 11, 2019	BUY	N/A	16,200	16,200 $242,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.2 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.1 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.

Account